Product Program year 2022 Source: CMS Open Payments

Sylvant

Drug Hematology

NDC 73090-420-01

Open in the dashboard

General payments

$214,992

3,375 payments

Research payments

$0

0 payments

Through program year 2022, $214,992 in general payments and $0 in research payments were reported against Sylvant (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2022 General $97,806 2,756
2021 General $117,186 619

Breakdown

Who paid General payments · program years 2021–2022
  1. EUSA Pharma (US) LLC $214,992 3,375 payments
Top recipients General payments · program year 2022
  1. Corey Casper Infectious Disease · Seattle, WA $12,266 13% · 15 payments
  2. Jadee Neff Hematology · Durham, NC $6,096 6% · 11 payments
  3. Amit Mehta Hematology & Oncology · Cary, NC $5,309 5% · 6 payments
  4. Sudipto Mukherjee Internal Medicine · Royal Oak, MI $4,000 4% · 1 payment
  5. Jaideep Shenoi Hematology & Oncology · Mount Vernon, WA $3,123 3% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Hematology & Oncology Internal Medicine $22,385 23% · 287 practitioners
  2. Endocrinology, Diabetes & Metabolism Internal Medicine $18,154 19% · 453 practitioners
  3. Infectious Disease Internal Medicine $12,328 13% · 2 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $8,790 9% · 196 practitioners
  5. Hematology Pathology $7,371 8% · 2 practitioners

The top 5 of 64 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Washington $16,741 17% · 41 recipients
  2. North Carolina $13,677 14% · 68 recipients
  3. Florida $7,531 8% · 253 recipients
  4. Texas $7,296 7% · 115 recipients
  5. California $7,160 7% · 173 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

3,375 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record